180 related articles for article (PubMed ID: 15607745)
1. The Wilms' tumor gene WT1 is a common marker of progenitor cells in fetal liver.
Kanato K; Hosen N; Yanagihara M; Nakagata N; Shirakata T; Nakazawa T; Nishida S; Tsuboi A; Kawakami M; Masuda T; Oka Y; Oji Y; Ijpenberg A; Hastie ND; Sugiyama H
Biochem Biophys Res Commun; 2005 Jan; 326(4):836-43. PubMed ID: 15607745
[TBL] [Abstract][Full Text] [Related]
2. Expression of Wilms' tumor suppressor in the liver with cirrhosis: relation to hepatocyte nuclear factor 4 and hepatocellular function.
Berasain C; Herrero JI; García-Trevijano ER; Avila MA; Esteban JI; Mato JM; Prieto J
Hepatology; 2003 Jul; 38(1):148-57. PubMed ID: 12829997
[TBL] [Abstract][Full Text] [Related]
3. Wilms' tumor 1 (WT1) gene in hematopoiesis: a surrogate marker of cell proliferation as a possible mechanism of action?
Olszewski M; Huang W; Chou PM; Duerst R; Kletzel M
Cytotherapy; 2005; 7(1):57-61. PubMed ID: 16040384
[TBL] [Abstract][Full Text] [Related]
4. The Wilms' tumor suppressor Wt1 activates transcription of the erythropoietin receptor in hematopoietic progenitor cells.
Kirschner KM; Hagen P; Hussels CS; Ballmaier M; Scholz H; Dame C
FASEB J; 2008 Aug; 22(8):2690-701. PubMed ID: 18424770
[TBL] [Abstract][Full Text] [Related]
5. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
Reizner N; Maor S; Sarfstein R; Abramovitch S; Welshons WV; Curran EM; Lee AV; Werner H
J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727
[TBL] [Abstract][Full Text] [Related]
6. The Wilms' tumor gene Wt1 is required for normal development of the retina.
Wagner KD; Wagner N; Vidal VP; Schley G; Wilhelm D; Schedl A; Englert C; Scholz H
EMBO J; 2002 Mar; 21(6):1398-405. PubMed ID: 11889045
[TBL] [Abstract][Full Text] [Related]
7. Hepatic progenitor cells in human fetal liver express the oval cell marker Thy-1.
Masson NM; Currie IS; Terrace JD; Garden OJ; Parks RW; Ross JA
Am J Physiol Gastrointest Liver Physiol; 2006 Jul; 291(1):G45-54. PubMed ID: 16769813
[TBL] [Abstract][Full Text] [Related]
8. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy.
Perugorria MJ; Castillo J; Latasa MU; Goñi S; Segura V; Sangro B; Prieto J; Avila MA; Berasain C
Cancer Res; 2009 Feb; 69(4):1358-67. PubMed ID: 19190340
[TBL] [Abstract][Full Text] [Related]
9. WT1 induces apoptosis through transcriptional regulation of the proapoptotic Bcl-2 family member Bak.
Morrison DJ; English MA; Licht JD
Cancer Res; 2005 Sep; 65(18):8174-82. PubMed ID: 16166292
[TBL] [Abstract][Full Text] [Related]
10. Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis.
Patek CE; Fleming S; Miles CG; Bellamy CO; Ladomery M; Spraggon L; Mullins J; Hastie ND; Hooper ML
Hum Mol Genet; 2003 Sep; 12(18):2379-94. PubMed ID: 12915483
[TBL] [Abstract][Full Text] [Related]
11. Wt1 is not essential for hematopoiesis in the mouse.
King-Underwood L; Little S; Baker M; Clutterbuck R; Delassus S; Enver T; Lebozer C; Min T; Moore A; Schedl A; Pritchard-Jones K
Leuk Res; 2005 Jul; 29(7):803-12. PubMed ID: 15927676
[TBL] [Abstract][Full Text] [Related]
12. RNAi silencing of the WT1 gene inhibits cell proliferation and induces apoptosis in the B16F10 murine melanoma cell line.
Zamora-Avila DE; Franco-Molina MA; Trejo-Avila LM; Rodríguez-Padilla C; Reséndez-Pérez D; Zapata-Benavides P
Melanoma Res; 2007 Dec; 17(6):341-8. PubMed ID: 17992115
[TBL] [Abstract][Full Text] [Related]
13. Identification and comparative expression analysis of a second wt1 gene in zebrafish.
Bollig F; Mehringer R; Perner B; Hartung C; Schäfer M; Schartl M; Volff JN; Winkler C; Englert C
Dev Dyn; 2006 Feb; 235(2):554-61. PubMed ID: 16292775
[TBL] [Abstract][Full Text] [Related]
14. Coexpression of Wilms' tumor suppressor 1 (WT1) and androgen receptor (AR) in the genital tract of human male embryos and regulation of AR promoter activity by WT1.
Köhler B; Delezoide AL; Boizet-Bonhoure B; McPhaul MJ; Sultan C; Lumbroso S
J Mol Endocrinol; 2007 May; 38(5):547-54. PubMed ID: 17496156
[TBL] [Abstract][Full Text] [Related]
15. Vascular biology and the sex of flies: regulation of vascular smooth muscle cell proliferation by wilms' tumor 1-associating protein.
Small TW; Penalva LO; Pickering JG
Trends Cardiovasc Med; 2007 Oct; 17(7):230-4. PubMed ID: 17936204
[TBL] [Abstract][Full Text] [Related]
16. Wilms' tumor gene 1 (WT1) expression in subtypes of acute lymphoblastic leukemia (ALL) of adults and impact on clinical outcome.
Busse A; Gökbuget N; Siehl JM; Hoelzer D; Schwartz S; Rietz A; Thiel E; Keilholz U
Ann Hematol; 2009 Dec; 88(12):1199-205. PubMed ID: 19404640
[TBL] [Abstract][Full Text] [Related]
17. The major podocyte protein nephrin is transcriptionally activated by the Wilms' tumor suppressor WT1.
Wagner N; Wagner KD; Xing Y; Scholz H; Schedl A
J Am Soc Nephrol; 2004 Dec; 15(12):3044-51. PubMed ID: 15579507
[TBL] [Abstract][Full Text] [Related]
18. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
Han Y; San-Marina S; Yang L; Khoury H; Minden MD
Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
[TBL] [Abstract][Full Text] [Related]
19. Wilms' tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells.
Glienke W; Maute L; Wicht J; Bergmann L
Eur J Cancer; 2009 Mar; 45(5):874-80. PubMed ID: 19196508
[TBL] [Abstract][Full Text] [Related]
20. Cancer immunotherapy targeting Wilms' tumor gene WT1 product.
Sugiyama H
Expert Rev Vaccines; 2005 Aug; 4(4):503-12. PubMed ID: 16117707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]